WILMINGTON, N.C., Feb. 24 /PRNewswire-FirstCall/ --
aaiPharma Inc. (Nasdaq: AAII) today announced that Dr. Philip Tabbiner,
President and Chief Executive Officer of aaiPharma, will be presenting at the
Raymond James 24th Annual Institutional Investors Conference on Monday, March
3, at 11:45 AM (EST). The conference is being held in Orlando, Florida.
The presentation will be webcast live over the Internet, then archived and
available for 10 days following the event. The audio-only webcast will be
accessible through the Company's website at http://www.aaipharma.com.
About aaiPharma
aaiPharma Inc. is a science-based specialty pharmaceutical company
headquartered in Wilmington, North Carolina, with more than 23 years of drug
development experience. In addition to developing and marketing its own line
of proprietary pharmaceutical products, aaiPharma continues to be a world
leader in providing contract pharmaceutical development services through its
AAI International division. For more information on the Company, please visit
the website at http://www.aaipharma.com.
SOURCE aaiParma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
Mr. James B. Sloan, Jr., Senior Vice
President, Corporate Finance of aaiPharma Inc., +1-910-254-7690
|
